chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: M
Vaccine: FLU3
Symptoms: Hypoaesthesia, Hypokinesia, Injection site pain, Vaccine positive rechallenge
Clinical narrative: Pain at left upper arm and shoulder area when patient moves the arm above head or behind the back. Also experiences numbness in same location along with pain. These symptoms last about 2 minutes then resolve per the patient. Symptoms started about 2 days post vaccination. Patient has not received any formal treatment.
Age: 1.7
Sex: M
Vaccine: DTAP, HEPA, PNC
Symptoms: Injection site reaction
Clinical narrative: Local reaction 3/3 LT, sx care spoke to Dr.
Age: 2.0
Sex: M
Vaccine: HEPA
Symptoms: Diarrhoea, Oedema, Pruritus, Rash, Upper respiratory tract infection
Clinical narrative: URI SX and diarrhea x 3d, no temp, rash all over body and 1 area on cheek, itchy seen in office by DR, to use Benadryl or calamine. Seen in urgent care 2/25, edema to hands/feet, using Benadryl no improvement. No distress in breathing. If rash worsen to start Oraped. No 2/28 did not use oraped child better.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Apnoea, Brain oedema, Cardiac arrest, Cardiac failure congestive, Convulsion
Clinical narrative: Pt had seizure, stopped breathing following day after receiving vaccinations. 12/11/04 requiring emergency treatment and hospitalization.  4/27/06 Review of 16- page d/c summary indicated gasping & cyanotic at onset of AE. also cardiac arrest, CHF, shock, severe metabolic acidosis, cerebral edema. Reviewed 90-page lab no new medical diagnoses.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Cyanosis, Dyspnoea, Metabolic acidosis, Shock
Clinical narrative: Pt had seizure, stopped breathing following day after receiving vaccinations. 12/11/04 requiring emergency treatment and hospitalization.  4/27/06 Review of 16- page d/c summary indicated gasping & cyanotic at onset of AE. also cardiac arrest, CHF, shock, severe metabolic acidosis, cerebral edema. Reviewed 90-page lab no new medical diagnoses.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Oedema, Pruritus
Clinical narrative: Went swimming on 3/12/05, mom noticed swelling in right arm, no c/o symptoms at that time after pool time swelling and itching occurred. waited until 3/13/05 6:00am took child to ER treated with Benadryl Keflex, discharged 4-5 hours later, follow up PMD next day no other problems or fever noted follow up today with PMD, Parent advised to watch for 3-5 days if not better return to PMD.
Age: 2.0
Sex: F
Vaccine: HEPA, PNC
Symptoms: Injection site erythema, Tenderness
Clinical narrative: Left thigh erythema 8cm x 5cm tenderness around inj site. Has full ROM.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Dysphagia, Nausea, Vomiting, Wheezing
Clinical narrative: 2/14/06 Pt felt nausea, vomiting, difficult swallowing and wheezingin the evening at 2000 hrs approx 10 hrs after vaccine (2/14/06 1035). Pt had expressed no allergy to eggs or problems with previous vaccination. 2/15/06 Pt reported ernesis/nausea that cleared up by mid-day.
Age: 40.0
Sex: M
Vaccine: DTAPH, FLU3, IPV, PPV
Symptoms: Erythema, Myalgia, Pyrexia, Swelling
Clinical narrative: Fever 101-102, myalgias, swelling, redness moderate 8 cm diameter both deltoid for 5 days following immunization.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Feeling hot, Pain, Rash
Clinical narrative: 2-4 cm x2cm red erythematous macular on back of rt arm, 1-4x4cm red erythematous macular on back of L arm-warm to touch painful.
Age: 62.0
Sex: F
Vaccine: PPV
Symptoms: Injection site reaction
Clinical narrative: Local reaction to pneumovax given on 03/06/2006.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Anaphylactic reaction, Bradycardia, Hypotonia, Pallor, Syncope vasovagal
Clinical narrative: Patient within 5-10' after receiving these immunization, loss tone, became pale, and dropped heart rate 60". - 3/29/06 Review of 3-page medical record lists diagnoses as anaphylactoid reaction secondary to immunizations. Vasovagal response.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Urticaria
Clinical narrative: Patient broke out in hives the same day as vaccine given.  Triage nurse advised to give Benadryl, called patient on 10/18/2005 - doing well, hives have resolved.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Bronchospasm, Cough, Urticaria, Vomiting, Wheezing
Clinical narrative: Generalized urticaria, vomiting, bronchospasm - coughing, wheezing. Treated with Orapred, Albuterol nebulizer.
Age: 15.0
Sex: F
Vaccine: HEP, IPV, MMR, TD
Symptoms: Convulsion, Dizziness, Loss of consciousness, Musculoskeletal stiffness
Clinical narrative: 2 minutes after the shot was administered, patient looked dizzy.  She was helped to sit down on a couch.  Then she stiffened into seizure.  All extremities stiff and loss of consciousness for 15 seconds.  When she cam to she was confused then sleepy.  She rested, and vital signs were checked.  She was observed for an hour and then sent to the clinic.
Age: 0.18
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Swelling
Clinical narrative: Right leg swollen 4 1/2 cm - red, baby was crying.
Age: 1.59
Sex: M
Vaccine: DTAP
Symptoms: Flushing, Petechiae, Pyrexia, Rash papular, Vomiting
Clinical narrative: On 03/02/2006 patient had onset of emesis and fever.  Seen at urgent care.  Flushed cheeks and increased bowel sounds.  Seen on 03/03/2006 for onset of rash, had papules and some petechiae and fever to 103 degrees.  Seen on 03/06/2006 for spreading rash.  Papular on extremities, torso, and some lacey rash as well.
Age: 18.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: Asthenia, Erythema, Hypersensitivity, Nausea, Pruritus
Clinical narrative: Parent called to say that client had reaction approximately 24 hours after administration on 02/28/06 - when client was at volleyball practice (3/1/06) she began to experience itchy ears, nose and toes.  When client took off her shoes, her toes were red and rashy.  Client's body then got red and she was feeling weak and nauseated.  Client was then transported to E.R. and was given Benadryl and IV hydration fluids.  MD did state that she had an "allergic reaction".  Client was then sent home with instructions on the Benadryl and rest.  Parent stated that client is much better today (3/2/06) and that the rash had receded.
Age: 18.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: Rash
Clinical narrative: Parent called to say that client had reaction approximately 24 hours after administration on 02/28/06 - when client was at volleyball practice (3/1/06) she began to experience itchy ears, nose and toes.  When client took off her shoes, her toes were red and rashy.  Client's body then got red and she was feeling weak and nauseated.  Client was then transported to E.R. and was given Benadryl and IV hydration fluids.  MD did state that she had an "allergic reaction".  Client was then sent home with instructions on the Benadryl and rest.  Parent stated that client is much better today (3/2/06) and that the rash had receded.
Age: 73.0
Sex: F
Vaccine: TD
Symptoms: Rash papular
Clinical narrative: Papular rash noted on left deltoid this 03-08-06 AM.  Area is 2" by 2 1/2" inferior to the injection site.  Left deltoid is generally sore.  No other rash noted or other symptoms.  Afebrile and no symptoms of infection.  Previous Td history unknown.
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Irritability, Rash maculo-papular
Clinical narrative: 03/06/2006 developed discrete macula papular rash, slightly, irritable otherwise well.
Age: 38.0
Sex: M
Vaccine: HEPAB
Symptoms: Contusion, Hypoaesthesia, Pain
Clinical narrative: Complaint of pain upper arm for 3 days.  Day 7 complaint of bruising and swelling.  02/24/2006 complaint of numbness, left buttock to foot, still present.
Age: 1.02
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Rash
Clinical narrative: Rash.  Treated with Benadryl.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Dysarthria, Eye disorder, Facial palsy, Hemiparesis, Movement disorder
Clinical narrative: Serious Criteria: Other: Medically Significant (OMIC). Initial information received on 17/Nov/2005 from the Centers for Disease Control and Prevention under the VAERS identification number 247328. A 19 year old female patient with no significant past medical history received a first dose of Menactra, lot number illegible, intra-muscularly in the left deltoid on 18/Aug/2005 at 13:00. One day later, the patient was unable to move "half her lips" and was unable to blink her left eye. She could not control her left nostril and could not feel the left side of her face. The following day the symptoms had improved. She was seen in an subsequently recovered from these events. Follow-up information received on 30/Nov/ 2005 from the Centers for Disease Control and Prevention. The lot number is provided as U16844?. The patient's emergency room visit was either 19/Aug/2005 or 20/Aug/2005. Follow-up information received on 27/Feb/2006 from a physician. Per the reporter, the lot number of U1684AA is the correct lot number of the Menactra that was administered on 18/Aug/2005. At the time of this report, it was reported that the patient had a history of Herpes Simplex Virus with no current lesions that was being treated with Valtrex beginning in September 2004. She has a significant family history of Bell's palsy, diabetes and hypertension. She also had a mild infection from an ear piercing on the left ear prior to the vaccination that was treated with Augmentin. Per the medical records received, the patient was seen in the emergency room on 21/Aug/2005 were she was treated with Prednisone 20mg BID, natural tears for her left eye, a left eye patch for dryness prevention and a CT of the brain was completed for facial drooping. The results of the CT scan were negative. CBC and Chemistry on 21/Aug/2005 were normal. A neurology consult was completed on 23/Aug/2005. The patient presented with left hemifacial droop, unable to close her left eye, unable to produce tears in the left eye, left facial paresthesias with symmetric intact sensation to light touch and vibration, disturbance in her chewing with no swallowing problems, very mild dysarthria with speech, left hemifacial weakness with difficulty frowning on the left side of the forehead and difficulty closing the left eye. She was negative for dysdiadochokinesis and her stretch reflex was a 1/4 at the biceps and patellar. Clonus and Rhomberg tests were negative, and her gait was normal. Diagnosis was Bell's palsy. Her recommended treatment was to continue the Prednisone and massage the left side of her face periodically and to continue to wear the eye patch at night to prevent dryness and use eye drops. She was to be re-evaluated in two months.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Paraesthesia, Sensory disturbance
Clinical narrative: Serious Criteria: Other: Medically Significant (OMIC). Initial information received on 17/Nov/2005 from the Centers for Disease Control and Prevention under the VAERS identification number 247328. A 19 year old female patient with no significant past medical history received a first dose of Menactra, lot number illegible, intra-muscularly in the left deltoid on 18/Aug/2005 at 13:00. One day later, the patient was unable to move "half her lips" and was unable to blink her left eye. She could not control her left nostril and could not feel the left side of her face. The following day the symptoms had improved. She was seen in an subsequently recovered from these events. Follow-up information received on 30/Nov/ 2005 from the Centers for Disease Control and Prevention. The lot number is provided as U16844?. The patient's emergency room visit was either 19/Aug/2005 or 20/Aug/2005. Follow-up information received on 27/Feb/2006 from a physician. Per the reporter, the lot number of U1684AA is the correct lot number of the Menactra that was administered on 18/Aug/2005. At the time of this report, it was reported that the patient had a history of Herpes Simplex Virus with no current lesions that was being treated with Valtrex beginning in September 2004. She has a significant family history of Bell's palsy, diabetes and hypertension. She also had a mild infection from an ear piercing on the left ear prior to the vaccination that was treated with Augmentin. Per the medical records received, the patient was seen in the emergency room on 21/Aug/2005 were she was treated with Prednisone 20mg BID, natural tears for her left eye, a left eye patch for dryness prevention and a CT of the brain was completed for facial drooping. The results of the CT scan were negative. CBC and Chemistry on 21/Aug/2005 were normal. A neurology consult was completed on 23/Aug/2005. The patient presented with left hemifacial droop, unable to close her left eye, unable to produce tears in the left eye, left facial paresthesias with symmetric intact sensation to light touch and vibration, disturbance in her chewing with no swallowing problems, very mild dysarthria with speech, left hemifacial weakness with difficulty frowning on the left side of the forehead and difficulty closing the left eye. She was negative for dysdiadochokinesis and her stretch reflex was a 1/4 at the biceps and patellar. Clonus and Rhomberg tests were negative, and her gait was normal. Diagnosis was Bell's palsy. Her recommended treatment was to continue the Prednisone and massage the left side of her face periodically and to continue to wear the eye patch at night to prevent dryness and use eye drops. She was to be re-evaluated in two months.
Sex: M
Vaccine: PPV, PPV
Symptoms: Anaemia, Anaphylactic reaction, Arthralgia, Blood creatinine increased, Chills
Clinical narrative: Information has been received from a registered nurse concerning a healthy male who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. subsequently, the patient went into anaphylactic shock and was hospitalized on 2/17/2006 and received dialysis. At the time of this report, the patient remains hospitalized on dialysis. A chest X ray was normal. The patients anaphylactic shock persisted. No product quality complaint was involved. Anaphylactic shock was considered to be immediately life threatening and disabling. Additional information has been requested.
Sex: M
Vaccine: PPV, PPV
Symptoms: Haematuria, Hypotension, Myalgia, Pyrexia, Renal failure
Clinical narrative: Information has been received from a registered nurse concerning a healthy male who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. subsequently, the patient went into anaphylactic shock and was hospitalized on 2/17/2006 and received dialysis. At the time of this report, the patient remains hospitalized on dialysis. A chest X ray was normal. The patients anaphylactic shock persisted. No product quality complaint was involved. Anaphylactic shock was considered to be immediately life threatening and disabling. Additional information has been requested.
Sex: M
Vaccine: PPV, PPV
Symptoms: Serum sickness, Sinusitis, White blood cell count increased
Clinical narrative: Information has been received from a registered nurse concerning a healthy male who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. subsequently, the patient went into anaphylactic shock and was hospitalized on 2/17/2006 and received dialysis. At the time of this report, the patient remains hospitalized on dialysis. A chest X ray was normal. The patients anaphylactic shock persisted. No product quality complaint was involved. Anaphylactic shock was considered to be immediately life threatening and disabling. Additional information has been requested.
Sex: M
Vaccine: PPV, PPV
Symptoms: Anaphylactic shock
Clinical narrative: Information has been received from a registered nurse concerning a healthy male who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. subsequently, the patient went into anaphylactic shock and was hospitalized on 2/17/2006 and received dialysis. At the time of this report, the patient remains hospitalized on dialysis. A chest X ray was normal. The patients anaphylactic shock persisted. No product quality complaint was involved. Anaphylactic shock was considered to be immediately life threatening and disabling. Additional information has been requested.
Sex: M
Vaccine: PNC
Symptoms: Autism
Clinical narrative: This case was considered medically important (OMIC). Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a consumer regarding a male patient who developed autism. The patient received a dose on an unspecified date. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day. Concomitant medications were not reported. A consumer reported that her son had developed autism. She declined further information stating that she feels that his condition has nothing to do with our vaccine. No additional information was available at the time of this report.
Sex: U
Vaccine: HEP, HIBV, MMR, PNC
Symptoms: Antisocial behaviour, Aphasia, Immune system disorder, Mental retardation severity unspecified, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a child who, as an infant, was vaccinated with a dose of hepatitis B virus vaccine rHBsAg yeast manufacturer unknown. the alleged result of receiving the mercury contained in the thimerosal containing vaccinations is that he suffers, and will continue to suffer, neurological and immunological damage with symptoms including, but no limited to, developmental delay, loss of language, and failure to meet social and motor milestones. Upon internal review, neurological and immunological damage, developmental delay, loss of language, and failure to meet social and motor milestones were determined to be other important medical events (OMIC). No further information is available.
Sex: U
Vaccine: HEP, HIBV, MMR, PNC
Symptoms: Neurodevelopmental disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a child who, as an infant, was vaccinated with a dose of hepatitis B virus vaccine rHBsAg yeast manufacturer unknown. the alleged result of receiving the mercury contained in the thimerosal containing vaccinations is that he suffers, and will continue to suffer, neurological and immunological damage with symptoms including, but no limited to, developmental delay, loss of language, and failure to meet social and motor milestones. Upon internal review, neurological and immunological damage, developmental delay, loss of language, and failure to meet social and motor milestones were determined to be other important medical events (OMIC). No further information is available.
Sex: U
Vaccine: HEP, HIBV, MMR, PNC
Symptoms: Autism, Drug toxicity, Neurodevelopmental disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a child who, as an infant, was vaccinated with a dose of hepatitis B virus vaccine rHBsAg yeast manufacturer unknown. the alleged result of receiving the mercury contained in the thimerosal containing vaccinations is that he suffers, and will continue to suffer, neurological and immunological damage with symptoms including, but no limited to, developmental delay, loss of language, and failure to meet social and motor milestones. Upon internal review, neurological and immunological damage, developmental delay, loss of language, and failure to meet social and motor milestones were determined to be other important medical events (OMIC). No further information is available.
Age: 55.0
Sex: M
Vaccine: HEP
Symptoms: Blindness, Hypertension, Laboratory test abnormal, Lipids increased, Nephrolithiasis
Clinical narrative: Loss of 75% vision right eye, vision still deteriorating. 3/16/06 Received medical records from PCP which included opth. reports.  PMH: HTN, dyslipidemia, nephrolithiasis.  Dx:P anterior ischemic optic neuropathy related to Viagra use; high hyperopia./ss3/28/06 Received medical records from opth.  No new information found/ss
Age: 55.0
Sex: M
Vaccine: HEP
Symptoms: Optic neuritis
Clinical narrative: Loss of 75% vision right eye, vision still deteriorating. 3/16/06 Received medical records from PCP which included opth. reports.  PMH: HTN, dyslipidemia, nephrolithiasis.  Dx:P anterior ischemic optic neuropathy related to Viagra use; high hyperopia./ss3/28/06 Received medical records from opth.  No new information found/ss
Age: 4.0
Sex: F
Vaccine: FLU3, PNC
Symptoms: Contusion, Pruritus, Skin discolouration, Swelling
Clinical narrative: Had 2 shots, one in each arm. Lt arm in morning, upper arm "grew big," red/purple, swollen, itching, skin very dark in color. Only local itching. From shoulder to elbow Mom describes swelling. Seen by MD given cephalexin supervision. Mom reports arm "smaller after medicine.
Age: 38.0
Sex: M
Vaccine: HEPA, TDAP
Symptoms: Convulsion, Hot flush, Hypoxia, Loss of consciousness
Clinical narrative: Within 10 seconds of administering TDAP patient experienced seizure activity lasting approximately 25 seconds.  Patient regained consciousness, was yawning continuously, complained of being hot.  Patient laid in supine position on floor and administered oxygen by mask, took multiple sets of vitals, called EMD and at 2:10P patient decided to go to urgent care on his own with help from wife.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Hot flush, Nausea
Clinical narrative: Patient states she received the flu vaccine at 9AM.  Around 12 Noon she began to feel nauseated, had diarrhea felt dizzy and had hot flashes.  She left work and went home.  By 4PM that day she was feeling much better.  Did not go see a doctor.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Dizziness, Influenza like illness, Nausea, Pyrexia
Clinical narrative: Per patient approximately 3 hours after receiving flu vaccine, patient experienced uncontrollable shaking, fever 101 degrees lasting 1-1 1/2 hours.  Also nauseated, dizziness, severe aches in joints, felt like coming down with the flu.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Tremor
Clinical narrative: Per patient approximately 3 hours after receiving flu vaccine, patient experienced uncontrollable shaking, fever 101 degrees lasting 1-1 1/2 hours.  Also nauseated, dizziness, severe aches in joints, felt like coming down with the flu.
Age: 76.0
Sex: M
Vaccine: FLUX
Symptoms: Oedema
Clinical narrative: Left arm was swollen from my shoulder to my wrist. For a week.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Joint range of motion decreased, Pain, Rotator cuff syndrome, Skin burning sensation
Clinical narrative: A couple hours after the flu shot, I felt pain at the site of the shot as well as a burning sensation in my fingers, upper and lower arm. This was accompanied a few days later by loss of motion and soreness. About 12 weeks later I was diagnosed with rotator cuff tendinitis. It has been treated with Aleve then with a cortisone shot.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Tendonitis
Clinical narrative: A couple hours after the flu shot, I felt pain at the site of the shot as well as a burning sensation in my fingers, upper and lower arm. This was accompanied a few days later by loss of motion and soreness. About 12 weeks later I was diagnosed with rotator cuff tendinitis. It has been treated with Aleve then with a cortisone shot.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Injection site reaction, Myalgia, Shoulder pain
Clinical narrative: Sore arm since vaccine was administered. Woke up on 3/2/06 with pain in the shoulder and arm muscle. In arm vaccinated with the pneumococcal vaccine.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Pt received varicella vaccine from PMD. PT developed non vesicular rash 12 days after vaccine. Pt received vaccine as requirement for kidney transplant. Pt adm to hospital 2/21 - 2/27 for fever
Age: 34.0
Sex: F
Vaccine: HEP
Symptoms: Cellulitis, Dizziness, Feeling hot
Clinical narrative: Depo Provera 150mg IM R deltoid, Hepatitis B 1.0ml in L deltoid, client c/o feeling lightheaded after receiving injections instructed her to put head between legs, cool pack to forehead and neck and she was given something to drink, lightheadedness resolved and she stated she felt ok when she left clinic, instructed her to get something to eat and she verbalized understanding. Clients mother telephoned into clinic stating that client had called her and told her my arm is hot and I have red streaks going up my neck, advised client's mother that client needs to go to the emergency dept now. Advised clients mother that client can call the national vaccine injury compensation program and get help paying for hospital visit, clients mother verbalized understanding and stated she would tell relay my instructions to her, I telephoned clients cell phone and it is not a working number, I will file a VAERS form and check with Emergency dept to see if client went or not. I telephoned hospital emergency dept and spoke with a RN and she verified that client was seen by MD and discharged home.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Oedema, Pyrexia
Clinical narrative: On 10/19/2005 child woke up with swelling on neck at jaw line. Also had fever.
Age: 27.0
Sex: F
Vaccine: HEP, HEPA, TD
Symptoms: Chills, Decreased appetite, Erythema, Injection site pain, Injection site reaction
Clinical narrative: Evening of 2/21/06 temp 102, with chills, decreased appetite, 2/22/06 2:45pm erythema 40mm diameter pain at injection site of TD left deltoid.
Age: 27.0
Sex: F
Vaccine: HEP, HEPA, TD
Symptoms: Pyrexia
Clinical narrative: Evening of 2/21/06 temp 102, with chills, decreased appetite, 2/22/06 2:45pm erythema 40mm diameter pain at injection site of TD left deltoid.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Contusion, Injection site hypersensitivity, Injection site oedema, Lethargy, Lymphadenopathy
Clinical narrative: Muscle soreness all over, especially legs, lethargy, glands in throat swollen, sore throat, injection site bruised, red, swollen.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Myalgia, Pharyngolaryngeal pain
Clinical narrative: Muscle soreness all over, especially legs, lethargy, glands in throat swollen, sore throat, injection site bruised, red, swollen.
Age: 6.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Swelling
Clinical narrative: Given pneumovax, had redness and swelling.
Age: 1.24
Sex: F
Vaccine: DTAPH, MMR, PNC, VARCEL
Symptoms: Crying, Rash, Screaming
Clinical narrative: Mother states pt broke out in a rash last night 2/22/06 no temperature increased and patient cried >2 hrs. Mother took pt to Dr mother gave pt Benadryl.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Discomfort, Injection site hypersensitivity, Injection site induration
Clinical narrative: Day after DTaP given mom noticed redness to right upper arm. Child reports discomfort. Mom described area as having a knot. Today and yesterday mom notices it clears in the morning and is more red in the PM mom has been giving Tylenol PRN discomfort.
Age: 38.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Approximately 10cm Diameters erythema and slight induration around injection site.
Age: 39.0
Sex: F
Vaccine: TD
Symptoms: Pain
Clinical narrative: Severe body aches starting 2/12 about 12 hours after injection lasting almost 4 days.
Age: 5.0
Sex: F
Vaccine: BCG, DTAP
Symptoms: Injection site oedema
Clinical narrative: Immunizations given with swelling to left arm, improved by time of exam.
Age: 58.0
Sex: M
Vaccine: HEPA
Symptoms: Pruritus, Urticaria
Clinical narrative: On 03/01/2006, pruritus and urticaria on arms, legs, trunk, back, scalp.  On 03/04/2006 went to doctor, given prescription steroid and anti-histamine.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Chills, Dizziness, Hypoaesthesia, Pruritus, Rash
Clinical narrative: After injection had chills, lightheaded, pruritus, and rash.  Continues to have problems with numbness in hands and feet. Has tested positive for Epstein Barr Virus.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Viral infection
Clinical narrative: After injection had chills, lightheaded, pruritus, and rash.  Continues to have problems with numbness in hands and feet. Has tested positive for Epstein Barr Virus.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Agitation, Crying, Pain, Somnolence
Clinical narrative: Slept for 5-6 hours immediately after vaccination, would not wake up even for feedings despite attempts to wake her up. Cried inconsolably for 1-2 hours and apparently had pain lower extremities to touch a manipulation when woke up.
Age: 1.01
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Was diagnosed with chickenpox on 03/05/2006.
Age: 1.01
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Drug ineffective, Infection, Pyrexia, Skin ulcer
Clinical narrative: Low grade fever, 15 lesions.  Diagnosed with Varicella.  Treated with Acyclovir.
Age: 1.94
Sex: F
Vaccine: DTAPH
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Redness and swelling encompassing the upper 1/3 of left upper arm. C/O pain, warm compress applied to site. Redness and swelling resolved on evening of 3/1/06 with no further c/o pain.
Age: 0.4
Sex: M
Vaccine: PNC
Symptoms: Injection site hypersensitivity, Injection site swelling
Clinical narrative: Patient received pneumococcal (PCV7) vaccine on 1/17/06. Received phone call from mother on 1/19/06 to report excessive redness and swelling to site of injection measuring 3" x 4." Larger than expected local reaction.
Age: 1.01
Sex: M
Vaccine: UNK
Symptoms: Viral infection
Clinical narrative: Developed breakthrough Varicella.
Age: 1.02
Sex: M
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Presented in office with active varicella
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: 03/01/2006 appeared with lesions that were Dx varicella > 50 pox.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Chicken pox lesion on eyeball referral to peds. opth.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: Child has reddened slightly swollen area on R deltoid that is 3 inches x 2 1/2 inches and warm to touch. Child c/o pain Tuesday evening 3/8/06 and came in Thursday morning to Clinic. MD treated a Keflex and will return to clinic 3/16/06.
Age: 17.0
Sex: M
Vaccine: TD
Symptoms: Convulsion, Dizziness, Dyskinesia, Eye movement disorder, Incoherent
Clinical narrative: 3-4 min after administration of Td vaccine Child had seizure activity that included incoherent, eyes rolled back in head, head, neck and torso arched backward, Both upper and lower extremity jerking motions, pallor.  No recollection of event after seizure activity, but did c/o of nausea.  No emesis, but BM after event-not incontinent.  Pt reported dizziness prior to "falling asleep spell".  Recovered completely.  VS/WNL, transported per mom to ED.
Age: 17.0
Sex: M
Vaccine: TD
Symptoms: Nausea, Opisthotonus, Pallor
Clinical narrative: 3-4 min after administration of Td vaccine Child had seizure activity that included incoherent, eyes rolled back in head, head, neck and torso arched backward, Both upper and lower extremity jerking motions, pallor.  No recollection of event after seizure activity, but did c/o of nausea.  No emesis, but BM after event-not incontinent.  Pt reported dizziness prior to "falling asleep spell".  Recovered completely.  VS/WNL, transported per mom to ED.
Age: 77.0
Sex: F
Vaccine: HEP, HEPA, TDAP
Symptoms: Cough, Malaise, Pyrexia
Clinical narrative: Client reports that 24 hours after receiving vaccines for travel, she developed a fever of 101, with a productive cough, expectorating yellow-colored, thick mucous and experiencing general malaise.
Age: 0.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Swelling
Clinical narrative: LARGE LOCALIZED ERYTHEMA AND SWELLING. SEE ATTACHED PHOTO.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Eyelid oedema, Injection site induration, Irritability, Swelling
Clinical narrative: Several hours after patient received her 1st Prevnar vaccine in her right lateral thigh, her parents described her thigh as "swelling to twice its normal size" and noted fussiness and swelling around her eyelids. They took her to a nearby ER, where swelling and induration of the right lateral injection site was noted. There was no wheezing or drooling, and no swelling noted around the eyes. Her vital signs were all normal. She was given Tylenol and sent home.
Age: 1.02
Sex: M
Vaccine: HBHEPB, MMR, PNC, VARCEL
Symptoms: Contusion, Erythema, Tremor
Clinical narrative: Mom called office the next day and stated that child wouldn't put any weight on his L leg. She noticed that when he was standing in his crib that morning, his L leg was shaking. Mom noticed some redness and a small bruise. Doctor suggested putting ice packs on the injection spot and incourage him to use leg.
Age: 5.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Skin reaction
Clinical narrative: Localized skin reaction immediately after MMR and DTaP.  No hives nor systemic effects.
Age: 1.97
Sex: F
Vaccine: DTAP, HIBV, MMR, PNC
Symptoms: Bacterial infection, Rash
Clinical narrative: 2/22 Initial onset of lesions in diaper area (blisters) FNP prescribed Amoxil for treatment of staph of lesion on buttock and several (2-3) inguinal fold 2/27, not thought to be related to shots.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: Patient diagnosed with cellulitis at site of vacccine.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Feeling hot, Pyrexia, Swelling
Clinical narrative: RT ARM SWOLLEN, HOT, STARTING THE EVENING OF VACCINATION AND LASTING UNTIL 3 DAYS AFTERWARDS. SHE ALSO HAD A FEVER OF 103 PER MOM ON 3/6 IN THE EVENING, AND 102.5 3/8 IN THE PM. PARENT INSTRUCTED TO USE ICE PACKS AND GIVE BENADRYL IN ADDITION TO USE OF ANALGESICS.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Tenderness, redness over left thigh around site of injection (10cmx 14cm)noted 1 day after administration of vaccine. Will give Clindamycin oral.
Age: 0.49
Sex: F
Vaccine: HEP, PNC, HEP, PNC
Symptoms: Rash maculo-papular
Clinical narrative: Information has been received from a health professional concerning a 25 week old  female, with no medical history and no allergies, who on 28Jul05, at 10:30AM, was  vaccinated with an IM first dose in the leg of hepatitis B virus vaccine rHBsAg (yeast) (Lot 648359/0473P). Concomitant vaccine administered on the same day and time included a first dose in the leg of pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (Prevnar)  (lot A94431A). There was no illness at the time of vaccination and no adverse events following prior vaccination. It was reported that on the same day the pt developed a rash all over with no fever. The pt was treated with prednisolone sodium phosphate (Pediapred) and an injection of epinephrine. It was noted that it was unk if there were any breathing problems or other allergic symptoms present besides the rash. It was reported that the pt was recovering. No product quality complaint was involved. No other information was provided. Follow up information from a physician indicated that the pt had a red, maculopapular rash within 2-3 hrs after vaccination with pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (crm197) (Prevnar) and hep B virus vaccine rHBsAg (yeast). The pt was given an injection of epinephrine when pt returned to the office with a rash over her body. Follow up information from a physician indicated that the pt was seen one week after being given epinephrine and all of the rash was gone. It was reported that the pt had recovered and the child was doing well with no problems. Additional information is not expected.
Age: 0.49
Sex: F
Vaccine: HEP, PNC, HEP, PNC
Symptoms: Hypersensitivity, Rash
Clinical narrative: Information has been received from a health professional concerning a 25 week old  female, with no medical history and no allergies, who on 28Jul05, at 10:30AM, was  vaccinated with an IM first dose in the leg of hepatitis B virus vaccine rHBsAg (yeast) (Lot 648359/0473P). Concomitant vaccine administered on the same day and time included a first dose in the leg of pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (Prevnar)  (lot A94431A). There was no illness at the time of vaccination and no adverse events following prior vaccination. It was reported that on the same day the pt developed a rash all over with no fever. The pt was treated with prednisolone sodium phosphate (Pediapred) and an injection of epinephrine. It was noted that it was unk if there were any breathing problems or other allergic symptoms present besides the rash. It was reported that the pt was recovering. No product quality complaint was involved. No other information was provided. Follow up information from a physician indicated that the pt had a red, maculopapular rash within 2-3 hrs after vaccination with pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (crm197) (Prevnar) and hep B virus vaccine rHBsAg (yeast). The pt was given an injection of epinephrine when pt returned to the office with a rash over her body. Follow up information from a physician indicated that the pt was seen one week after being given epinephrine and all of the rash was gone. It was reported that the pt had recovered and the child was doing well with no problems. Additional information is not expected.
Age: 13.0
Sex: F
Vaccine: MNQ
Symptoms: Eye disorder, Lacrimation increased, Optic neuritis, Vision blurred
Clinical narrative: Initial report received on 11/17/2005 under the VAERS ID number 242648. A 14 year old female patient with no significant medical history had received her first intramuscular injection of Menactra, lot number U1658AA, in the right arm on 7/18/2005. Seven days later the right eye was red, watery and had blurred vision. The patient had no experienced any trauma to the eye. She was referred to an ophthalmologist who admitted her to the hospital. She was diagnosed with optic neuritis on 7/28/2005 and was treated with intravenous steroids and antibiotics. Per the reporter, the patient had recovered from these events at the time of this report. Follow up information received on 11/30/2005. the patient has a pre existing history of an allergy to iodine contrast media and pneumonia at the age of eight. The patient was hospitalised from 7/28/2005 to 7/31/2005 and recovered from that event. The patient had a recurrence of the event and was re hospitalized on 8/31/2005. Recovery status for the recurrence of the event was not reported. Follow up information received on 1/6/2006. The patient had a preexisting condition of surgery for non cancerous bone tumor that was removed from the knee. Also, hospital admission and discharge dated of second hospitalization  was 8/31/2006 to 9/3/2005. Recovery status was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Confusional state, Facial palsy, Hypoaesthesia, Injection site hypersensitivity, Paraesthesia
Clinical narrative: Initial report received on 17/Nov/2005 from the CDCP under the VAERS reference number 243145. An 11 year old female patient with a medical history of benign cardiac arrhythmia and Bell's palsy in September 2004 had received her first administration (route not reported) of Menactra, lot number U1574AA,in the left deltoid on 09/Aug/2005. 24 hours later, the patient experienced local redness at the injection site. At an unspecified time later, she felt numbness in the left upper and lower extremities that was accompanied by an episode of acute confusion. The numbness and confusion lasted approximately four - six hours. At an unspecified time the patient began vomiting and had transient signs of Bell's Palsy that lasted less than 30 minutes. Per the reporter the patient recovered from the above adverse events six hours after the events began. The patient had a brief recurrence of the above symptoms seven days later that lasted less than one hour. The patient was seen by a physician on 18/Aug/2005 and on exam, the patient was found to be entirely normal except for very mild facial weakness. Medications used to treat these adverse events were Benadryl and Reglan. At the time of this report, the patient had recovered from all adverse events except the mild facial weakness. Follow-up information received on 30/Nov/2005 from the CDCP. The patient has a history of shingles (Sep/2003). At the time of the event, the patient also experienced tingling on the left side of the body. She was examined in an emergency room on 16/Aug/2005. Follow-up from CISA, indicates the patient has improved (no date reported) Per the CDC report, the recovery status is unknown.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Vomiting
Clinical narrative: Initial report received on 17/Nov/2005 from the CDCP under the VAERS reference number 243145. An 11 year old female patient with a medical history of benign cardiac arrhythmia and Bell's palsy in September 2004 had received her first administration (route not reported) of Menactra, lot number U1574AA,in the left deltoid on 09/Aug/2005. 24 hours later, the patient experienced local redness at the injection site. At an unspecified time later, she felt numbness in the left upper and lower extremities that was accompanied by an episode of acute confusion. The numbness and confusion lasted approximately four - six hours. At an unspecified time the patient began vomiting and had transient signs of Bell's Palsy that lasted less than 30 minutes. Per the reporter the patient recovered from the above adverse events six hours after the events began. The patient had a brief recurrence of the above symptoms seven days later that lasted less than one hour. The patient was seen by a physician on 18/Aug/2005 and on exam, the patient was found to be entirely normal except for very mild facial weakness. Medications used to treat these adverse events were Benadryl and Reglan. At the time of this report, the patient had recovered from all adverse events except the mild facial weakness. Follow-up information received on 30/Nov/2005 from the CDCP. The patient has a history of shingles (Sep/2003). At the time of the event, the patient also experienced tingling on the left side of the body. She was examined in an emergency room on 16/Aug/2005. Follow-up from CISA, indicates the patient has improved (no date reported) Per the CDC report, the recovery status is unknown.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Arthralgia, Bacterial infection, Liver function test abnormal, Mononucleosis syndrome, Pain
Clinical narrative: (OMIC) Initial report received on 11/17/2005 under the VAERS reference number 244839. A 16 year old male patient had received an intramuscular injection of Menactra, lot number 414941AB (erroneous lot number), on 5/2/2005. He was ill with mononucleosis at the time of the vaccination. On 9/4/2005 he experienced pain in his legs. On 9/7/2005 he went to ER with hip pain. He was seen in the office by a neurologist on 9/8/2005 who admitted him to the hospital. On 9/9/2005 an Electromyogram was completed and he had a lumbar puncture protein of 90, increased liver function test and mononucleosis with 30 percent atypical lymphs. On 9/10/2005 he was released to home and again re hospitalized on 9/15/2005 for intravenous immune globulin therapy times five days. He had a magnetic resonance imaging test completed that showed inflammation roots cauda aguina. At the time of this report the patient had recovered from these adverse events. Lab results reportedly indicate the adverse event is probably due to Epstein Barr virus. Additional information received on 11/30/2005. The lot number has been clarified to read U1494AB. The patient has a history of asthma and steroid use for poison ivy. A Mono test on an unspecified date was positive.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Proteinuria, Viral infection
Clinical narrative: (OMIC) Initial report received on 11/17/2005 under the VAERS reference number 244839. A 16 year old male patient had received an intramuscular injection of Menactra, lot number 414941AB (erroneous lot number), on 5/2/2005. He was ill with mononucleosis at the time of the vaccination. On 9/4/2005 he experienced pain in his legs. On 9/7/2005 he went to ER with hip pain. He was seen in the office by a neurologist on 9/8/2005 who admitted him to the hospital. On 9/9/2005 an Electromyogram was completed and he had a lumbar puncture protein of 90, increased liver function test and mononucleosis with 30 percent atypical lymphs. On 9/10/2005 he was released to home and again re hospitalized on 9/15/2005 for intravenous immune globulin therapy times five days. He had a magnetic resonance imaging test completed that showed inflammation roots cauda aguina. At the time of this report the patient had recovered from these adverse events. Lab results reportedly indicate the adverse event is probably due to Epstein Barr virus. Additional information received on 11/30/2005. The lot number has been clarified to read U1494AB. The patient has a history of asthma and steroid use for poison ivy. A Mono test on an unspecified date was positive.
Age: 15.0
Sex: M
Vaccine: FLU3, MNQ
Symptoms: Facial palsy, Headache, Hypoaesthesia, Tongue disorder
Clinical narrative: (OMIC) Initial report received on 11/30/2005. A 15 year old male patient with a medical history of asthma had received an administration route and site not reported of Menactra, lot number U1821AA and a flu vaccine (manufacturer, route, site and lot number not reported) on 10/21/2005. Three days later, on 10/24/2005 the patient developed Bells palsy. Testing was done for Lyme disease and it was negative. The patient had a clinic visit and he was improving on 10/31/2005. Follow up information received on 12/09/2005. On 10/21/2005, the patient was vaccinated with a intramuscular, unspecified arm injection of Menactra, lot number U1821AA and an intramuscular, right arm injection of Fluzone SV 2005-2006 USP, lot number U1850AA. On 10/24/2005 at 6:00pm, the patient developed numbness of his tongue and a headache. On 10/25/2005, he was examined by the school nurse and complained of numbness of the right side of his face. He was then examined by his physician and diagnosed with Bells palsy. There was no illness at the time of vaccination, and other medications include a Maxair inhaler.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Convulsion, Difficulty in walking, Dysarthria, Encephalitis
Clinical narrative: Initial report received from the CDCP (VAERS numbers 246935) on 30/Nov/2005. A 12 year old male patient with a history of allergic rhinitis, bipolar disorder, attention deficit hyperactive disorder (ADHD) was taking Zyrtec, Depakote, Concerta and Singulair at the time he received an administration (route and site not reported ) of Menactra, lot number U1677AA on 11/Aug/2005. Twenty-two days later on 02/Sep/2005 he developed encephalitis and seizures. On 19/Sep/2005 he was admitted to a rehabilitation center and discharges on 21/Oct/2005. After discharge from the rehabilitation center he was able to perform most activities of daily living. Follow-up received on 06/Jan/2006 from the CDCP. In the report, under recovery status it is noted that the patient is "walking with a rolling walker with moderate assist" and "dysarthria." The events of encephalitis and seizures were reported in a a patient with an underlying condition of bipolar disorder and attention deficit hyperactive disorder. Concomitant medication included Concerta (Methylphenidate HCL). There is some clinical evidence that methylphenidate may lower the convulsive threshold in patient with prior history of seizures, in patients with prior ESG evidence of seizures. Further information including but not limited to the patient's history and physical, the hospital discharge summary, the results of the laboratory studies, imaging studies and the cerebrospinal fluid analysis, procedures and consult, is needed in order to complete the medical assessment. Follow-up (06 January 2006): The follow-up information does not change the previous medical assessment (OMIC).